Related Experiment Video
Updated: Jul 28, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Non-healing facial lesions: cutaneous old world leishmaniasis in dresden
U Wollina1, A Koch1, J Schönlebe2
1Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany.
Abstract:
Cutaneous leishmaniasis is a common vector-borne disease world-wide but not in Central Europe. The typical clinical manifestation is an enlarging papule on the site of infection. Vectors are sandflies and reservoirs may be wild animals like rodents, dogs or even humans. Patients with any kind of immunodeficiency are at risk. We report on two otherwise healthy patients, 16 and 18 years-of-age, who presented non-healing facial lesions. The diagnosis of cutaneous leishmaniasis was confirmed through intracellular amastigotes in Giemsa stains of skin biopsies. One infection was of Syrian origin and the other was contracted in Tuscany. Since both lesions were classified as complex cutaneous lesions, drug therapy was initiated with itraconazole orally or intralesional meglumine antimonite. A complete response was obtained in both patients. No other adverse effects rather than injection pain with meglumine antimonite were observed. We should be aware of cutaneous leishmaniasis in travelers returning from endemic regions or from migrants and refugees from endemic regions.
More Related Videos
09:43Controlled Semi-Automated Laser-Induced Injuries for Studying Spinal Cord Regeneration in Zebrafish Larvae
Published on: November 22, 2021
05:46Author Spotlight: Immune-Mediated Bone Regeneration — The Critical Role of Macrophages and Controlled Immunomodulation in Restorative Processes
Published on: September 6, 2024
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Leishmaniasis
Healing II: Complications
Antiprotozoal Agents